Real-World Effectiveness and Safety of Ritlecitinib in Adolescents with Severe Alopecia Areata: A 36-Week

Michela Starace1, Stephano Cedirian1, Francesca Pampaloni1

  • 1Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Italy.

Abstract

No abstract available in PubMed .